This adds further to the suggestion that targeting IL-6 may weaken a pro-inflammatory state and influential pro-inflammatory cytokines IL-6, TNF-α and IFN-γ might represent important biomarkers, and key targets for immune-based therapies in schizophrenia. This evidence concerns the gene IL6 and schizophrenia.